Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-TS21-001, Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS); Amended Notice of Meeting, 22051 [2021-08550]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices
modify, obtain, or otherwise support
any equipment or services produced or
provided by a company that poses a
national security threat to the integrity
of communications networks or the
communications supply chain.
On March 12, 2020, the President
signed into law the Secure and Trusted
Communications Networks Act of 2019
(Secure Networks Act), Public Law 116–
124, 133 Stat. 158 (2020) (codified as
amended at 47 U.S.C. 1601–1609),
which among other measures, directs
the FCC to establish the Secure and
Trusted Communications Networks
Reimbursement Program
(Reimbursement Program). This
program is intended to provide funding
to providers of advanced
communications service for the
removal, replacement and disposal of
certain communications equipment and
services that poses an unacceptable
national security risk (i.e., covered
equipment and services) from their
networks. The Commission has
designated two entities—Huawei
Technologies Company (Huawei) and
ZTE Corporation (ZTE), along with their
affiliates, subsidiaries, and parents—as
covered companies posing such a
national security threat. See Protecting
Against National Security Threats to the
Communications Supply Chain Through
FCC Programs—Huawei Designation, PS
Docket No. 19–351, Memorandum
Opinion and Order, 35 FCC Rcd 14435
(2020); Protecting Against National
Security Threats to the Communications
Supply Chain Through FCC Programs—
ZTE Designation, PS Docket No. 19–352,
Memorandum Opinion and Order, DA
20–1399 (PSHSB rel. Nov. 24, 2020).
On December 10, 2020, the
Commission adopted the Second Report
and Order implementing the Secure
Networks Act, which contained certain
new information collection
requirements. See Protecting Against
National Security Threats to the
Communications Supply Chain Through
FCC Programs, WC Docket No. 18–89,
Second Report and Order, 35 FCC Rcd
14284 (2020) (Second Report and
Order). These requirements will allow
the Commission to receive, review and
make eligibility determinations and
funding decisions on applications to
participate in the Reimbursement
Program that are filed by certain
providers of advanced communications
service. These new information
collection requirements will also assist
the Commission in processing funding
disbursement requests and in
monitoring and furthering compliance
with applicable program requirements
to protect against waste, fraud, and
abuse.
VerDate Sep<11>2014
18:01 Apr 23, 2021
Jkt 253001
On December 27, 2020, the President
signed into law the Consolidated
Appropriations Act, 2021, appropriating
$1.9 billion to ‘‘carry out’’ the
Reimbursement Program and amending
the Reimbursement Program eligibility
requirements to expand eligibility to
include providers of advanced
communications service with 10 million
or fewer subscribers. See Public Law
116–260, Division N-Additional
Coronavirus Response and Relief, Title
IX-Broadband internet Access Service,
sections 901, 906, 134 Stat. 1182 (2020).
The Commission has interpreted the
term ‘‘provider of advanced
communications service’’ to mean
‘‘facilities-based providers, whether
fixed or mobile, with a broadband
connection to end users with at least
200 kbps in one direction.’’ Second
Report and Order, 35 FCC Rcd at 14332,
para. 111. Participation in the
Reimbursement Program is voluntary
but compliance with the new
information collection requirements is
required to obtain Reimbursement
Program support.
The Secure Networks Act requires all
providers of advanced communications
service to annually report, with
exception, on whether they have
purchased, rented, leased or otherwise
obtained covered communications
equipment or service on or after certain
dates. 47 U.S.C. 1603(d)(2)(B). The
Second Report and Order adopted a
new information collection requirement
to implement this statutory mandate.
See Secure Networks Act section 5. If
the provider certifies it does not have
any covered equipment and services,
then the provider is not required to
subsequently file an annual report,
unless it later obtains covered
equipment and services. Second Report
and Order at para. 215.
This submission is for new
information collection requirements
contained in the Second Report and
Order adopted by the Commission on
December 10, 2020. The new
requirements are necessary for the
creation of a $1.9 billion reimbursement
program, as directed by Congress in the
Secure Networks Act, as amended. This
submission also covers a related
information collection requirement
necessitated by the Secure Networks Act
and/or the Second Report and Order
and proposes to eliminate a previously
approved information collection
requirement that is no longer necessary.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—TS21–001,
Identify and Evaluate Potential Risk
Factors for Amyotrophic Lateral
Sclerosis (ALS); Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—TS21–
001, Identify and Evaluate Potential
Risk Factors for Amyotrophic Lateral
Sclerosis (ALS); June 10, 2021, 10:00
a.m.–5:00 p.m., EDT, in the original
FRN. The web conference meeting was
published in the Federal Register on
February 1, 2021, Volume 86, Number
19, pages 7725–7726.
The meeting is being amended to
change the meeting time and should
read as follows:
Date: June 10, 2021.
Time: 8:30 a.m.–5:00 p.m., EDT.
Place: Web Conference.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Mikel Walters, Ph.D., Scientific Review
Officer, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway, NE, Mailstop F–63,
Atlanta, Georgia 30341–3717,
Telephone: (404) 639–0913, MWalters@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–08550 Filed 4–23–21; 8:45 am]
BILLING CODE 4163–18–P
Federal Communications Commission.
Marlene Dortch,
Secretary. Office of the Secretary.
[FR Doc. 2021–08546 Filed 4–23–21; 8:45 am]
BILLING CODE 6712–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 9990
22051
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 86, Number 78 (Monday, April 26, 2021)]
[Notices]
[Page 22051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08550]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--TS21-001, Identify and Evaluate Potential Risk
Factors for Amyotrophic Lateral Sclerosis (ALS); Amended Notice of
Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--TS21-001, Identify and Evaluate Potential Risk Factors for
Amyotrophic Lateral Sclerosis (ALS); June 10, 2021, 10:00 a.m.-5:00
p.m., EDT, in the original FRN. The web conference meeting was
published in the Federal Register on February 1, 2021, Volume 86,
Number 19, pages 7725-7726.
The meeting is being amended to change the meeting time and should
read as follows:
Date: June 10, 2021.
Time: 8:30 a.m.-5:00 p.m., EDT.
Place: Web Conference.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific
Review Officer, National Center for Injury Prevention and Control, CDC,
4770 Buford Highway, NE, Mailstop F-63, Atlanta, Georgia 30341-3717,
Telephone: (404) 639-0913, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-08550 Filed 4-23-21; 8:45 am]
BILLING CODE 4163-18-P
